Technetium Tc-99m tilmanocept Recruiting Phase 2 Trials for Rhabdomyosarcomas / Melanoma Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs